Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "community-healthcare"

6 News Found

Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore
News | April 07, 2026

Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore

The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management


Vedanta Aluminium launches 24x7 telemedicine facility in Odisha
Healthcare | May 08, 2026

Vedanta Aluminium launches 24x7 telemedicine facility in Odisha

Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region


ARTEMIS study shows significant gains in adolescent mental health across urban slums in India
Healthcare | May 01, 2026

ARTEMIS study shows significant gains in adolescent mental health across urban slums in India

The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada


IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach
Healthcare | April 27, 2026

IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach

The deal signals a clear push to expand access to care in underserved regions


Mankind Pharma launches 45-day healthcare mission at Mahakumbh
Healthcare | January 28, 2025

Mankind Pharma launches 45-day healthcare mission at Mahakumbh

The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring


Parexel expands patient access to clinical trials through new community alliance network
Clinical Trials | June 21, 2022

Parexel expands patient access to clinical trials through new community alliance network

Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials